• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • Q&A
    • Videos
    • Comment
    • Analysis
    • People moves
    • In Profile
  •  
    Analysis
    • Videos
    • Q&A
    • Comment
    • In Profile
    • Podcast
    • Fundraising
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Early-stage

FRANCE/US - CAPE leads $8m Bizanga funding

Crédit Agricole Private Equity has led an $8m investment into US-based software company Bizanga, alongside returning investor Galileo Partners.

  • Early-stage
  • 18 February 2009
IRELAND - Novartis et al. invest EUR 18m into Opsona

Novartis Venture Fund, Foundtain Heathcare Partners, Inventages Venture Capital and Seroba Kernel Life Sciences have invested EUR 18m in a second round of funding for biotechnology company Opsona Therapueutics.

  • Early-stage
  • 18 February 2009
SWEDEN - Industrifonden and Broken Arrow back Conveneer with SEK 36m

Swedish government-backed venture fund Industrifonden and a group of American investors operating under the name Broken Arrow have invested SEK 18m each into mobile technology company Conveneer.

  • Early-stage
  • 17 February 2009
ITALY - 360° invests EUR 5.4m into EPS

360° Capital Partners has led a EUR 5.4m funding round for renewable energy company Electro Power Systems (EPS).

  • Early-stage
  • 16 February 2009
GERMANY - HTGF invests EUR 500,000 into Liquiverse

High-Tech Gründerfonds has invested EUR 500,000 into software business Liquiverse.

  • Early-stage
  • 12 February 2009
FRANCE - Cerenis raises EUR 2.5m

Cerenis Therapeutics SA, which is backed by Alta Partners, EDF Ventures, HealthCap Private Equity, NIF Ventures, OrbiMed, Sofinnova Partners and TVM Capital, has raised EUR 2.5m from OSEO, a French public holding company that provides financial support...

  • Early-stage
  • 11 February 2009
NORWAY - Northzone et al. back ChapDrive with NOK 52m

Existing investors NorthZone Ventures, Hafslund Ventures and Energy Capital Management (formerly StatoilHydro Ventures), alongside new backers StatoilHydro and Innvovation Norway, have invested NOK 52m into Chapdrive, a developer of patented systems for...

  • Early-stage
  • 11 February 2009
UK - NorthStar invests £420,000 into MySapient

NorthStar has invested ТЃ420,000 as part of a ТЃ610,000 funding round for virtual gaming site MySapient.com, with the management and directors of the company providing the balance.

  • Early-stage
  • 10 February 2009
GERMANY/US - Neuhaus and ERP back sofatronic

Returning backer Neuhaus Partners and ERP-Startfond have invested an undisclosed seven-figure sum into blue-ray company sofatronic GmbH in a second round of funding.

  • Early-stage
  • 10 February 2009
BELGIUM - GIMV et al. invest EUR 13.5m into ActoGeniX

A consortium of investors, including existing backers Gimv, Biotech Fund Flanders, Baekeland Fund, VIB, LSP, Aescap Venture and Ventech, as well as new investor Biovest, have invested EUR 13.5m round into biopharmaceutical business ActoGeniX in a series-B...

  • Early-stage
  • 10 February 2009
GERMANY - TGFS invests in UroTec GmbH

Technologiegründerfonds Sachsen (TGFS) has invested in Dresden-based biotechnology company UroTec GmbH.

  • Early-stage
  • 09 February 2009
FRANCE - Neptune Technologies backs EUR 3m Squid Solutions funding

Neptune Technologies and Banque de Vizille, along with a number of private investors, have invested EUR 3m into Squid Solutions, a customer intelligence software company, in a first round of financing.

  • Early-stage
  • 09 February 2009
SWEDEN - Chalmers et al. provide SEK 1.5m for Syspiro

Chalmers Innovation has, together with Innovationsbron and business angels, provided a SEK 1.5m investment for medical equipment company Syspiro Diagnostics.

  • Early-stage
  • 06 February 2009
SWEDEN - Innovationsbron and Chalmers invest SEK 1.5m into Capeco

Chalmers Innovation, alongside Innovationsbron, has subscribed to a SEK 1.5 share issue for Capeco, a developer of encapsulating biocides to protect painted surfaces againt mold and algae growth.

  • Early-stage
  • 06 February 2009
GERMANY - High-Tech Gründerfonds invests in Microstim

High-Tech-Gründerfonds has invested EUR 500,000 in medical technology start-up company Microstim GmbH.

  • Early-stage
  • 05 February 2009
SPAIN - Bullnet backs Códice Software

Bullnet Capital has invested in software developer Códice Software.

  • Early-stage
  • 04 February 2009
UK - EV further supports Acal Energy and Medalytix

Enterprise Ventures (EV) has provided further funding to portfolio companies Acal Energy, a fuel cell business, and medical screening business Medalytix.

  • Early-stage
  • 03 February 2009
GERMANY - Hasso Plattner Ventures and KfW invest in VIOSO

Hasso Plattner Ventures has, alongside KfW, invested in smart projecting company VIOSO.

  • Early-stage
  • 30 January 2009
SWEDEN - Capricorn and SEB Venture invest EUR 3.3m into Xylophane

Capricorn Venture Partners, via Capricorn Cleantech Fund, and SEB Venture Capital have invested EUR 3.3m into renewable packaging material company Xylophane AB. The two firms join existing investor KTH Chalmers Capital, which has been involved with the...

  • Early-stage
  • 28 January 2009
UK - Albion makes first investment

Albion Ventures, formerly Close Ventures, has invested ТЃ2.5m as part of a ТЃ6.1m funding round into medical device company Forth Photonics, alongside Scottish Enterprise and current backer NBGI Ventures.

  • Early-stage
  • 28 January 2009
SWEDEN - Industrifonden backs QuiQom Systems

Government-backed Industrifonden has invested an undisclosed sum into QuiQom Systems, a developer of solutions for high-speed broadband access in residential properties.

  • Early-stage
  • 27 January 2009
NORWAY - Picasso et al. invest NOK 73m into Lytix

Norwegian drug developer Lytix Biopharma has secured NOK 73m funding from existing investors including Picasso Kapital AS, SåkornInvest Nord AS, The University of Tromsø and Norinnova AS, among others.

  • Early-stage
  • 23 January 2009
FRANCE - Sofinnova leads EUR 6m DBV funding

Sofinnova Partners has provided EUR 4m as part of a EUR 6m financing round for biopharmaceutical company DBV Technologies, with the balance being supplied by new investor ALK-Abello, a leading worldwide immunotherapy company.

  • Early-stage
  • 22 January 2009
UK - Delphic acquires iQur

Delphic Ltd, a provider of specialist diagnostics for HIV backed by MMC Ventures, The Capital Fund and Ulive Enterprise, has acquired the diagnostics business of biotechnology company iQur.

  • Early-stage
  • 20 January 2009
737475
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013